Local view for "http://purl.org/linkedpolitics/eu/plenary/2002-02-27-Speech-3-097"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20020227.6.3-097"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spoken text |
"Mr President, the Parliament's committees on which I sit have in the last few days made important progress with legislation on both financial services and energy market liberalisation. It will be tragic if the European Council cannot also match Europe's urgent needs and their own rhetoric at Lisbon and bring this area of legislation to completion and soon.
Beyond this, I stress the critical importance of research and development and innovation to the future of Europe. Mr Prodi highlighted this policy area and said quite rightly there is no reason why Europe should not lead the world in biotechnology, which is undoubtedly going to be the leading area of science and industry, of employment and improved quality of life for the next few decades. And yet, what do we have? Bickering over the Community patent, moratoria and antagonisms, procedural obstacles which have forestalled all progress in genetically modified crops and a tremendous promise they offer to us in Europe and the developing world especially. What do we have? Over-complex and expensive approval procedures and patenting processes for new products in healthcare and pharmaceuticals. We cannot afford to lose our best scientists to our competitors where they are better appreciated, given scope to realise their ambitions and are suitably rewarded.
We are already two years past Lisbon, there are only eight more years to 2010 when we are to be the most competitive and dynamic knowledge-based economy in the world. Action will speak louder than words, Mr President-in-Council, there is little or no time to lose."@en1
|
lpv:spokenAs | |
lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples